Dexloxiglumide

CAS: 119817-90-2

Ref. 3D-UEA81790

Produktinformation

• Name: Dexloxiglumide
• Synonyme: (4R)-4-[(3,4-Dichlorobenzoyl)amino]-5-[(3-methoxypropyl)pentylamino]-5-oxopentanoic acid, (R)-4-(3,4-Dichlorobenzamido)-5-((3-methoxypropyl)(pentyl)amino)-5-oxopentanoic acid, (R)-4-(3,4-Dichlorobenzamido)-N-(3-methoxypropyl)-N-pentylglutaramic acid, <span class="text-smallcaps">D</span>-Loxiglumide, Dexloxiglumida, Dexloxiglumida [INN-Spanish], Dexloxiglumide [INN], Dexloxiglumidum, Dexloxiglumidum [INN-Latin], N~2~-(3,4-dichlorobenzoyl)-N-(3-methoxypropyl)-N-pentyl-D-alpha-glutamine, Pentanoic Acid, 4-[(3,4-Dichlorobenzoyl)Amino]-5-[(3-Methoxypropyl)Pentylamino]-5-Oxo-, (4R)-, Pentanoic acid, 4-[(3,4-dichlorobenzoyl)amino]-5-[(3-methoxypropyl)pentylamino]-5-oxo-, (R)-

Beschreibung

Dexloxiglumide is a drug that is used to treat bowel disease. It has been shown to be effective in patients with inflammatory bowel disease and occipital cortex lesions who have an elevated risk of bowel perforation. Dexloxiglumide is a prodrug that undergoes hepatic metabolism, which leads to the formation of active metabolites. This drug binds to the nuclear receptor PPAR-γ, which may play a role in its therapeutic effects in the treatment of inflammation.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 461.38 g/mol
• Formel: C₂₁H₃₀Cl₂N₂O₅
• Reinheit: Min. 95%